Reanalysis of Clinical Trial Data Confirms LipiGesic® M has Robust Efficacy for Treatment of Migraine Headache and Associated Symptoms
PuraMed BioScience®, Inc., (PMBS: OTCBB) announces that the reanalysis of the clinical trial results of its homeopathic formulation, LipiGesic® M, found that the migraine medication has “robust efficacy.” These results were featured in the February 2013 issue of Headache: The Journal of Head and Face Pain, the official journal of the American Headache Society®. The [...]



Studies show that LipiGesic M works as well as prescription migraine medication. LipiGesic M has been declared a highly effective, first-line treatment for acute migraine pain.